Skip to content

Clinical trials

Phase 2 Leukemia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 2 Country / region: Germany Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20042
20061
20073
20082
20094
20102
20111
20121
20132
20141
20151
20181
20201
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting3
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Amgen Research (Munich) GmbH3
Bristol-Myers Squibb2
European Organisation for Research and Treatment of Cancer - EORTC2
Pfizer2
AbbVie1
Aegera Therapeutics1
Amgen1
Cancer Trials Ireland1
Cephalon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia30
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Recurrence6
Leukemia, Myeloid, Acute5
Leukemia, Lymphocytic, Chronic, B-Cell4
Neoplasms4
Hematologic Diseases3
Leukemia, Myeloid3
Lymphatic Diseases3

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.